ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
84,765
-1,32%
Bitcoin
57 110,61
-5,76%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) Actualités

GSK GSK plc

42,42
0,98 (2,36%)
Avant marché
Dernière mise à jour : 11:33:42
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
GSK plc GSK NYSE Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,98 2,36% 42,42 11:33:42
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
41,44
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202413:48IHMARKETNEWSAnglo American Rejects BHP Group’s Offer, Toyota Invests..
16/3/202413:00BWPositive RUBY phase III data show potential for Jemperli..
08/3/202418:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202418:00BWGSK Doubles COiMMUNITY Grant Funding, Launches Patient..
07/3/202412:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202417:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202419:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202418:30EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
05/3/202418:10EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202416:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202415:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:11IHMARKETNEWSShares of WW International Plummet after Oprah Exits, EA..
26/2/202416:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202416:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202412:34IHMARKETNEWSCisco Systems Stock Drops 5% Following Restructuring Plan,..
08/2/202413:00GLOBEAlector Announces First Patient Dosed in PROGRESS-AD Phase 2..
07/2/202422:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
07/2/202413:00GLOBEFDA Grants Latozinemab Breakthrough Therapy Designation for..
06/2/202413:00BWGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in..
01/2/202412:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202419:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202412:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
30/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202412:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202420:11BWElegen e GSK firmano un accordo di collaborazione e di..
24/1/202418:52BWElegen und GSK unterzeichnen Kooperations- und..
24/1/202417:37BWElegen et GSK signent un accord de collaboration et de..
24/1/202414:00BWElegen and GSK Sign Collaboration and Licensing Agreement to..
19/1/202422:20EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202417:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202413:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
17/1/202418:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202412:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
17/1/202410:04DJNCorrection to GSK Article on Tuesday
17/1/202408:44DJNGSK Sells Haleon Shares Valued Around $1.24 Billion Through..
16/1/202419:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202418:19DJNGSK to Sell Haleon Shares Worth Around $1.27 Billion
10/1/202412:21IHMARKETNEWSWall Street Highlights: Tesla Launches Restyled Model 3,..
09/1/202412:37DJNTrending: GSK Buys Asthma-Specialist Aiolos Bio For Up To..
09/1/202412:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
09/1/202411:52BWGSK Enters Agreement to Acquire Aiolos Bio
09/1/202410:01DJFRGSK achète Aiolos, spécialisé dans les maladies..
09/1/202409:35DJNGSK Expands Respiratory Pipeline With Aiolos Bio Buy -- 2nd..

Dernières Valeurs Consultées

NYSE
GSK
GSK
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés